OMER logo

OMEROmeros Corp

$8.63
$1.55
(15.23%)
Today
Updated: 11:48 AM EDT
Reported EarningsMay 13
Mkt Cap$736.78M
Vol4.82M
News
all
press releases
Bears are Losing Control Over Omeros (OMER), Here's Why It's a 'Buy' Now
Omeros (OMER) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks
News Placeholder
More News
News Placeholder
OMER Stock Gains Ground As Commercial Rollout Of Yartemlea Exceeds Expectations
Yartemlea net sales in Q1 came in at $9.9 million, higher than the $4.1 million expected by Wall Street.
Stocktwits
News Placeholder
Omeros Corporation Reports First Quarter 2026 Financial Results
Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2026, which include: First Quarter and Recent...
Business Wire
News Placeholder
Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026
Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the first quarter 2026 on Wednesday, May 13, 2026 after market close. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss...
Business Wire
News Placeholder
Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway
Medical Products stocks face tariff and cost pressures, but Phibro Animal Health and peers leverage innovation, AI and demand trends to drive growth.
Zacks
News Placeholder
Omeros (NASDAQ:OMER) Trading 6.3% Higher - Should You Buy?
Omeros (NASDAQ:OMER) Stock Price Up 6.3% - Should You Buy...
MarketBeat
News Placeholder
Here's Why Omeros (OMER) is a Great Momentum Stock to Buy
Does Omeros (OMER) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
News Placeholder
Wall Street Analysts Believe Omeros (OMER) Could Rally 222.76%: Here's is How to Trade
The consensus price target hints at a 222.8% upside potential for Omeros (OMER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks
News Placeholder
4 Medical Product Stocks to Buy From a Challenging Industry
The Zacks Medical - Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. PAHC, BLFS, OMER and BWAY reflect the favorable fundamentals.
Zacks
News Placeholder
Omeros (NASDAQ:OMER) Lowered to Hold Rating by Wall Street Zen
Wall Street Zen lowered Omeros from a "buy" rating to a "hold" rating in a research note on Sunday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.